Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0002018274-26-000002

Options or other derivatives

  • Chief Medical Officer acquired 108,854 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Redfield Robert Chief Medical Officer 2026-03-08 Grant or award · Stock Option (right to buy) +108,854 108,854 D
Loading xslF345X05/form4-03102026_110357.xml…